Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Song Ren's publication output changed over time?
ScholarIQpublication output · 1991–2024
Output grew0% over the shown period — from 1 works in 1991 to 1 in 2024.
1
1
1
1
2
1
1
2
1
199119971998200320072016201720182024
What are the most-cited papers on Song Ren?
ScholarIQmost cited works
Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation
George B. McDonald, John T. Slattery, M Bouvier, Song Ren, Ami Batchelder, Thomas F. Kalhorn, H. Gary Schoch, Claudio Anasetti, Ted Gooley
Blood. 2003386 Citations
Oxidation of cyclophosphamide to 4-hydroxycyclophosphamide and deschloroethylcyclophosphamide in human liver microsomes.
Song Ren, Ji Yang, Thomas F. Kalhorn, John T. Slattery
PubMed. 1997148 Citations
Rituximab Pharmacokinetics in Patients With Rheumatoid Arthritis: B‐Cell Levels Do Not Correlate With Clinical Response
Ferdinand C. Breedveld, Sunil Agarwal, Ming Yin, Song Ren, Nicole F. Li, Tim Shaw, Brian E. Davies
The Journal of Clinical Pharmacology. 2007148 Citations
Phase 1 Dose Escalation Study of MEDI-565, a Bispecific T-Cell Engager that Targets Human Carcinoembryonic Antigen, in Patients With Advanced Gastrointestinal Adenocarcinomas
Michael J. Pishvaian, Michael A. Morse, Jennifer McDevitt, Jonathan Norton, Song Ren, Gabriel J. Robbie, Patricia C. Ryan, Serguei Soukharev, Haifeng Bao, Crystal S. Denlinger
S112974357. 201696 Citations
Pharmacokinetics of cyclophosphamide and its metabolites in bone marrow transplantation patients*
Song Ren, Thomas F. Kalhorn, George B. McDonald, Claudio Anasetti, Frederick R. Appelbaum, John T. Slattery
S159852663. 199872 Citations
Related on ScholarIQ
University of Electronic Science and Technology of China
Institution
Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation
Paper
Oxidation of cyclophosphamide to 4-hydroxycyclophosphamide and deschloroethylcyclophosphamide in human liver microsomes.
Paper
Rituximab Pharmacokinetics in Patients With Rheumatoid Arthritis: B‐Cell Levels Do Not Correlate With Clinical Response
Paper
Phase 1 Dose Escalation Study of MEDI-565, a Bispecific T-Cell Engager that Targets Human Carcinoembryonic Antigen, in Patients With Advanced Gastrointestinal Adenocarcinomas
Paper
Pharmacokinetics of cyclophosphamide and its metabolites in bone marrow transplantation patients*
Paper